Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 13 to 24 of 29 entries
Sorted by: Best Match Show Resources per page
Recommended Papers of 2021 From the TMR Editorial Board.

Transfusion medicine reviews

Dzik S, Murphy M.
PMID: 34998657
Transfus Med Rev. 2021 Dec 11; doi: 10.1016/j.tmrv.2021.12.001. Epub 2021 Dec 11.

No abstract available.

Cite
Dzik S, Murphy M. Recommended Papers of 2021 From the TMR Editorial Board. Transfus Med Rev. 2021;doi: 10.1016/j.tmrv.2021.12.001.
Dzik, S., & Murphy, M. (2021). Recommended Papers of 2021 From the TMR Editorial Board. Transfusion medicine reviews, . https://doi.org/10.1016/j.tmrv.2021.12.001
Dzik, Sunny, and Murphy, Michael. "Recommended Papers of 2021 From the TMR Editorial Board." Transfusion medicine reviews vol. (2021). doi: https://doi.org/10.1016/j.tmrv.2021.12.001
Dzik S, Murphy M. Recommended Papers of 2021 From the TMR Editorial Board. Transfus Med Rev. 2021 Dec 11; doi: 10.1016/j.tmrv.2021.12.001. Epub 2021 Dec 11. PMID: 34998657; PMCID: PMC8730678.
Copy Download .nbib Format: NLM
Fibrinogen Replacement in Haemostatic Resuscitation: Dose, Laboratory Targets and Product Choice.

Transfusion medicine reviews

Curry N.
PMID: 34565636
Transfus Med Rev. 2021 Oct;35(4):104-107. doi: 10.1016/j.tmrv.2021.06.005. Epub 2021 Aug 25.

Fibrinogen is a key coagulation protein that is necessary for the formation of stable clots. Fibrinogen levels have been reported to be one of the first to fall during major haemorrhage reflecting consumption, dilution and fibrinogenolysis. Its role in...

Cite
Curry N. Fibrinogen Replacement in Haemostatic Resuscitation: Dose, Laboratory Targets and Product Choice. Transfus Med Rev. 2021;35(4):104-107doi: 10.1016/j.tmrv.2021.06.005.
Curry, N. (2021). Fibrinogen Replacement in Haemostatic Resuscitation: Dose, Laboratory Targets and Product Choice. Transfusion medicine reviews, 35(4), 104-107. https://doi.org/10.1016/j.tmrv.2021.06.005
Curry, Nicola. "Fibrinogen Replacement in Haemostatic Resuscitation: Dose, Laboratory Targets and Product Choice." Transfusion medicine reviews vol. 35,4 (2021): 104-107. doi: https://doi.org/10.1016/j.tmrv.2021.06.005
Curry N. Fibrinogen Replacement in Haemostatic Resuscitation: Dose, Laboratory Targets and Product Choice. Transfus Med Rev. 2021 Oct;35(4):104-107. doi: 10.1016/j.tmrv.2021.06.005. Epub 2021 Aug 25. PMID: 34565636.
Copy Download .nbib Format: NLM
New-Onset Methemoglobinemia After Receiving Ozone Autohemotherapy and High-Dose Vitamin C Injection.

Transfusion medicine reviews

Chen HJ, Lin KT, Chou CC, Lin YR.
PMID: 34815107
Transfus Med Rev. 2021 Oct 03; doi: 10.1016/j.tmrv.2021.07.006. Epub 2021 Oct 03.

No abstract available.

Cite
Chen HJ, Lin KT, Chou CC, et al. New-Onset Methemoglobinemia After Receiving Ozone Autohemotherapy and High-Dose Vitamin C Injection. Transfus Med Rev. 2021;doi: 10.1016/j.tmrv.2021.07.006.
Chen, H. J., Lin, K. T., Chou, C. C., & Lin, Y. R. (2021). New-Onset Methemoglobinemia After Receiving Ozone Autohemotherapy and High-Dose Vitamin C Injection. Transfusion medicine reviews, . https://doi.org/10.1016/j.tmrv.2021.07.006
Chen, Hao-Jen, et al. "New-Onset Methemoglobinemia After Receiving Ozone Autohemotherapy and High-Dose Vitamin C Injection." Transfusion medicine reviews vol. (2021). doi: https://doi.org/10.1016/j.tmrv.2021.07.006
Chen HJ, Lin KT, Chou CC, Lin YR. New-Onset Methemoglobinemia After Receiving Ozone Autohemotherapy and High-Dose Vitamin C Injection. Transfus Med Rev. 2021 Oct 03; doi: 10.1016/j.tmrv.2021.07.006. Epub 2021 Oct 03. PMID: 34815107.
Copy Download .nbib Format: NLM
Recommended Papers of 2021 From the TMR Editorial Board.

Transfusion medicine reviews

Dzik S, Murphy M.
PMID: 34998657
Transfus Med Rev. 2021 Dec 11; doi: 10.1016/j.tmrv.2021.12.001. Epub 2021 Dec 11.

No abstract available.

Cite
Dzik S, Murphy M. Recommended Papers of 2021 From the TMR Editorial Board. Transfus Med Rev. 2021;doi: 10.1016/j.tmrv.2021.12.001.
Dzik, S., & Murphy, M. (2021). Recommended Papers of 2021 From the TMR Editorial Board. Transfusion medicine reviews, . https://doi.org/10.1016/j.tmrv.2021.12.001
Dzik, Sunny, and Murphy, Michael. "Recommended Papers of 2021 From the TMR Editorial Board." Transfusion medicine reviews vol. (2021). doi: https://doi.org/10.1016/j.tmrv.2021.12.001
Dzik S, Murphy M. Recommended Papers of 2021 From the TMR Editorial Board. Transfus Med Rev. 2021 Dec 11; doi: 10.1016/j.tmrv.2021.12.001. Epub 2021 Dec 11. PMID: 34998657.
Copy Download .nbib Format: NLM
Recommended Papers of 2020 From the TMR Editorial Board.

Transfusion medicine reviews

Dzik S, Murphy M.
PMID: 33323211
Transfus Med Rev. 2021 Jan;35(1):1-6. doi: 10.1016/j.tmrv.2020.12.002. Epub 2020 Dec 07.

No abstract available.

Cite
Dzik S, Murphy M. Recommended Papers of 2020 From the TMR Editorial Board. Transfus Med Rev. 2020;35(1):1-6doi: 10.1016/j.tmrv.2020.12.002.
Dzik, S., Murphy, M. (2021). Recommended Papers of 2020 From the TMR Editorial Board. Transfusion medicine reviews, 35(1), 1-6. https://doi.org/10.1016/j.tmrv.2020.12.002
Dzik, Sunny, et al. "Recommended Papers of 2020 From the TMR Editorial Board." Transfusion medicine reviews vol. 35,1 (2021): 1-6. doi: https://doi.org/10.1016/j.tmrv.2020.12.002
Dzik S, Murphy M. Recommended Papers of 2020 From the TMR Editorial Board. Transfus Med Rev. 2021 Jan;35(1):1-6. doi: 10.1016/j.tmrv.2020.12.002. Epub 2020 Dec 07. PMID: 33323211.
Copy Download .nbib Format: NLM
Erratum to "Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk" (Transfusion Medicine Reviews 31/3 [2017] 154-164).

Transfusion medicine reviews

Kiely P, Gambhir M, Cheng AC, McQuilten ZK, Seed CR, Wood EM.
PMID: 28821369
Transfus Med Rev. 2018 Jan;32(1):66-68. doi: 10.1016/j.tmrv.2017.07.005. Epub 2017 Aug 15.

No abstract available.

Cite
Kiely P, Gambhir M, Cheng AC, et al. Erratum to "Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk" (Transfusion Medicine Reviews 31/3 [2017] 154-164). Transfus Med Rev. 2017;32(1):66-68doi: 10.1016/j.tmrv.2017.07.005.
Kiely, P., Gambhir, M., Cheng, A. C., McQuilten, Z. K., Seed, C. R., & Wood, E. M. (2018). Erratum to "Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk" (Transfusion Medicine Reviews 31/3 [2017] 154-164). Transfusion medicine reviews, 32(1), 66-68. https://doi.org/10.1016/j.tmrv.2017.07.005
Kiely, Philip, et al. "Erratum to "Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk" (Transfusion Medicine Reviews 31/3 [2017] 154-164)." Transfusion medicine reviews vol. 32,1 (2018): 66-68. doi: https://doi.org/10.1016/j.tmrv.2017.07.005
Kiely P, Gambhir M, Cheng AC, McQuilten ZK, Seed CR, Wood EM. Erratum to "Emerging Infectious Diseases and Blood Safety: Modeling the Transfusion-Transmission Risk" (Transfusion Medicine Reviews 31/3 [2017] 154-164). Transfus Med Rev. 2018 Jan;32(1):66-68. doi: 10.1016/j.tmrv.2017.07.005. Epub 2017 Aug 15. PMID: 28821369; PMCID: PMC8445249.
Copy Download .nbib Format: NLM
Acquired Antibodies to αIIbβ3 in Glanzmann Thrombasthenia: From Transfusion and Pregnancy to Bone Marrow Transplants and Beyond.

Transfusion medicine reviews

Nurden AT.
PMID: 29884513
Transfus Med Rev. 2018 May 23; doi: 10.1016/j.tmrv.2018.05.002. Epub 2018 May 23.

Patients with the inherited bleeding disorder Glanzmann thrombasthenia (GT) possess platelets that lack αIIbβ3 integrin and fail to aggregate, and have moderate to severe mucocutaneous bleeding. Many become refractory to platelet transfusions due to the formation of isoantibodies to...

Cite
Nurden AT. Acquired Antibodies to αIIbβ3 in Glanzmann Thrombasthenia: From Transfusion and Pregnancy to Bone Marrow Transplants and Beyond. Transfus Med Rev. 2018;doi: 10.1016/j.tmrv.2018.05.002.
Nurden, A. T. (2018). Acquired Antibodies to αIIbβ3 in Glanzmann Thrombasthenia: From Transfusion and Pregnancy to Bone Marrow Transplants and Beyond. Transfusion medicine reviews, . https://doi.org/10.1016/j.tmrv.2018.05.002
Nurden, Alan T. "Acquired Antibodies to αIIbβ3 in Glanzmann Thrombasthenia: From Transfusion and Pregnancy to Bone Marrow Transplants and Beyond." Transfusion medicine reviews vol. (2018). doi: https://doi.org/10.1016/j.tmrv.2018.05.002
Nurden AT. Acquired Antibodies to αIIbβ3 in Glanzmann Thrombasthenia: From Transfusion and Pregnancy to Bone Marrow Transplants and Beyond. Transfus Med Rev. 2018 May 23; doi: 10.1016/j.tmrv.2018.05.002. Epub 2018 May 23. PMID: 29884513.
Copy Download .nbib Format: NLM
Corrigendum to "Effect of age of red cells for transfusion on patient outcomes: a systematic review and meta-analysis" [Transfus Med Rev 32/2 (2018) 77-88].

Transfusion medicine reviews

McQuilten ZK, French CJ, Nichol A, Higgins A, Cooper DJ.
PMID: 32295729
Transfus Med Rev. 2020 Apr;34(2):138-139. doi: 10.1016/j.tmrv.2020.03.002. Epub 2020 Apr 12.

No abstract available.

Cite
McQuilten ZK, French CJ, Nichol A, et al. Corrigendum to "Effect of age of red cells for transfusion on patient outcomes: a systematic review and meta-analysis" [Transfus Med Rev 32/2 (2018) 77-88]. Transfus Med Rev. 2020;34(2):138-139doi: 10.1016/j.tmrv.2020.03.002.
McQuilten, Z. K., French, C. J., Nichol, A., Higgins, A., & Cooper, D. J. (2020). Corrigendum to "Effect of age of red cells for transfusion on patient outcomes: a systematic review and meta-analysis" [Transfus Med Rev 32/2 (2018) 77-88]. Transfusion medicine reviews, 34(2), 138-139. https://doi.org/10.1016/j.tmrv.2020.03.002
McQuilten, Zoe K, et al. "Corrigendum to "Effect of age of red cells for transfusion on patient outcomes: a systematic review and meta-analysis" [Transfus Med Rev 32/2 (2018) 77-88]." Transfusion medicine reviews vol. 34,2 (2020): 138-139. doi: https://doi.org/10.1016/j.tmrv.2020.03.002
McQuilten ZK, French CJ, Nichol A, Higgins A, Cooper DJ. Corrigendum to "Effect of age of red cells for transfusion on patient outcomes: a systematic review and meta-analysis" [Transfus Med Rev 32/2 (2018) 77-88]. Transfus Med Rev. 2020 Apr;34(2):138-139. doi: 10.1016/j.tmrv.2020.03.002. Epub 2020 Apr 12. PMID: 32295729.
Copy Download .nbib Format: NLM
The Paradox of Choice in Hemostatic Resuscitation: Still More Options Than Evidence, But a Good Start.

Transfusion medicine reviews

Stanworth S, Callum J.
PMID: 34598875
Transfus Med Rev. 2021 Oct;35(4):71-72. doi: 10.1016/j.tmrv.2021.08.005. Epub 2021 Sep 08.

No abstract available.

Cite
Stanworth S, Callum J. The Paradox of Choice in Hemostatic Resuscitation: Still More Options Than Evidence, But a Good Start. Transfus Med Rev. 2021;35(4):71-72doi: 10.1016/j.tmrv.2021.08.005.
Stanworth, S., & Callum, J. (2021). The Paradox of Choice in Hemostatic Resuscitation: Still More Options Than Evidence, But a Good Start. Transfusion medicine reviews, 35(4), 71-72. https://doi.org/10.1016/j.tmrv.2021.08.005
Stanworth, Simon, and Callum, Jeannie. "The Paradox of Choice in Hemostatic Resuscitation: Still More Options Than Evidence, But a Good Start." Transfusion medicine reviews vol. 35,4 (2021): 71-72. doi: https://doi.org/10.1016/j.tmrv.2021.08.005
Stanworth S, Callum J. The Paradox of Choice in Hemostatic Resuscitation: Still More Options Than Evidence, But a Good Start. Transfus Med Rev. 2021 Oct;35(4):71-72. doi: 10.1016/j.tmrv.2021.08.005. Epub 2021 Sep 08. PMID: 34598875.
Copy Download .nbib Format: NLM
Prehospital Tranexamic Acid (TXA) in Patients with Traumatic Brain Injury (TBI).

Transfusion medicine reviews

Maegele M.
PMID: 34598876
Transfus Med Rev. 2021 Oct;35(4):87-90. doi: 10.1016/j.tmrv.2021.08.003. Epub 2021 Sep 04.

Traumatic brain injury (TBI) remains a significant medical and socioeconomic challenge. The initial injury may be complicated by haemostatic derangements leading to exacerbation of lesions and haemorrhagic progression. The results from the CRASH-3 trial have promoted the implementation of...

Cite
Maegele M. Prehospital Tranexamic Acid (TXA) in Patients with Traumatic Brain Injury (TBI). Transfus Med Rev. 2021;35(4):87-90doi: 10.1016/j.tmrv.2021.08.003.
Maegele, M. (2021). Prehospital Tranexamic Acid (TXA) in Patients with Traumatic Brain Injury (TBI). Transfusion medicine reviews, 35(4), 87-90. https://doi.org/10.1016/j.tmrv.2021.08.003
Maegele, Marc. "Prehospital Tranexamic Acid (TXA) in Patients with Traumatic Brain Injury (TBI)." Transfusion medicine reviews vol. 35,4 (2021): 87-90. doi: https://doi.org/10.1016/j.tmrv.2021.08.003
Maegele M. Prehospital Tranexamic Acid (TXA) in Patients with Traumatic Brain Injury (TBI). Transfus Med Rev. 2021 Oct;35(4):87-90. doi: 10.1016/j.tmrv.2021.08.003. Epub 2021 Sep 04. PMID: 34598876.
Copy Download .nbib Format: NLM
Blood Donation Narratives on Social Media: A Topic Modeling Study.

Transfusion medicine reviews

Ramondt S, Kerkhof P, Merz EM.
PMID: 34810071
Transfus Med Rev. 2021 Oct 17; doi: 10.1016/j.tmrv.2021.10.001. Epub 2021 Oct 17.

Social media have shown great potential for producing significant changes in behavior and have become the cornerstone for many public health and agency efforts. The nonprofit sector -including blood collection agencies- has adopted social media to aid their cause...

Cite
Ramondt S, Kerkhof P, Merz EM. Blood Donation Narratives on Social Media: A Topic Modeling Study. Transfus Med Rev. 2021;doi: 10.1016/j.tmrv.2021.10.001.
Ramondt, S., Kerkhof, P., & Merz, E. M. (2021). Blood Donation Narratives on Social Media: A Topic Modeling Study. Transfusion medicine reviews, . https://doi.org/10.1016/j.tmrv.2021.10.001
Ramondt, Steven, et al. "Blood Donation Narratives on Social Media: A Topic Modeling Study." Transfusion medicine reviews vol. (2021). doi: https://doi.org/10.1016/j.tmrv.2021.10.001
Ramondt S, Kerkhof P, Merz EM. Blood Donation Narratives on Social Media: A Topic Modeling Study. Transfus Med Rev. 2021 Oct 17; doi: 10.1016/j.tmrv.2021.10.001. Epub 2021 Oct 17. PMID: 34810071.
Copy Download .nbib Format: NLM
The Role of Plasma Transfusion in Pre-Hospital Haemostatic Resuscitation.

Transfusion medicine reviews

Tucker H, Davenport R, Green L.
PMID: 34593289
Transfus Med Rev. 2021 Oct;35(4):91-95. doi: 10.1016/j.tmrv.2021.08.004. Epub 2021 Sep 05.

Traumatic haemorrhage remains a major cause of preventable death and early haemostatic resuscitation is now a mainstay of treatment internationally. Recently, 2 randomized control trials (RCTs) - PAMPer (Prehospital Air Medical Plasma) and COMBAT (Control of Major Bleeding After...

Cite
Tucker H, Davenport R, Green L. The Role of Plasma Transfusion in Pre-Hospital Haemostatic Resuscitation. Transfus Med Rev. 2021;35(4):91-95doi: 10.1016/j.tmrv.2021.08.004.
Tucker, H., Davenport, R., & Green, L. (2021). The Role of Plasma Transfusion in Pre-Hospital Haemostatic Resuscitation. Transfusion medicine reviews, 35(4), 91-95. https://doi.org/10.1016/j.tmrv.2021.08.004
Tucker, Harriet, et al. "The Role of Plasma Transfusion in Pre-Hospital Haemostatic Resuscitation." Transfusion medicine reviews vol. 35,4 (2021): 91-95. doi: https://doi.org/10.1016/j.tmrv.2021.08.004
Tucker H, Davenport R, Green L. The Role of Plasma Transfusion in Pre-Hospital Haemostatic Resuscitation. Transfus Med Rev. 2021 Oct;35(4):91-95. doi: 10.1016/j.tmrv.2021.08.004. Epub 2021 Sep 05. PMID: 34593289.
Copy Download .nbib Format: NLM
Showing 13 to 24 of 29 entries